Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,359 public trials 538 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT06375044

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer institution Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

NCT02235857

Conditions
Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Nemours/A.I. duPont Hospital for Children Wilmington, Delaware, United States
  • Nemours Children's Health Orlando, Florida, United States
View Trial Details
Recruiting

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

NCT07681596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View Trial Details
Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

NCT07010159

Conditions
Cardiovascular Diseases, Disease Attributes, Heart Diseases, +6 more
Locations
  • Investigational Site 018 Gilbert, Arizona, United States
  • Investigational Site 053 Phoenix, Arizona, United States
  • Investigational Site 030 Los Angeles, California, United States
  • Investigational Site 008 San Francisco, California, United States
View all 63 locations
View Trial Details
Recruiting

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma

NCT06016920

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
Locations
  • CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) Montpellier, France
  • University of Bergen, Haukeland University Hospital Bergen, Norway
  • Oslo Universitetssykehus Oslo, Norway
  • Uniwersyteckie Cetrum Kliniczne Gdansk, Poland
View Trial Details

Related conditions